Evaluation of differential gene expression in fluconazole-susceptible and -resistant isolates of Candida albicans by cDNA microarray analysis

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 11, 2002, Pages 3412-3417

  Rogers, P David ^a   Barker, Katherine S ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE ISOENZYME 2; ALDEHYDE DEHYDROGENASE ISOENZYME 5; FLUCONAZOLE; GENE PRODUCT; GLUTATHIONE PEROXIDASE 1; GLYCOSYLPHOSPHATIDYLINOSITOL; PROTEIN CDR1; PROTEIN CRD2; PROTEIN ERG2; PROTEIN FET34; PROTEIN FTR2; PROTEIN IFD5; PROTEIN RTA3; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO ACID METABOLISM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; DRUG EFFICACY; EVALUATION; FATTY ACID METABOLISM; FUNGUS ISOLATION; GENE EXPRESSION REGULATION; IRON TRANSPORT; LIPID METABOLISM; NONHUMAN; NUCLEOTIDE SEQUENCE; OROPHARYNX; PRIORITY JOURNAL; STEROL METABOLISM;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CARBOHYDRATE METABOLISM; CELL WALL; DNA PROBES; DNA, COMPLEMENTARY; DNA, FUNGAL; DRUG RESISTANCE, FUNGAL; ERGOSTEROL; FLUCONAZOLE; GENE EXPRESSION REGULATION, FUNGAL; IRON; MICROBIAL SENSITIVITY TESTS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, BACTERIAL;

EID: 0036839691     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.11.3412-3417.2002     Document Type: Article

References (43)

1. Andrews, N. C., M. D. Fleming, and H. Gunshin. 1999. Iron transport across biologic membranes. Nutr. Rev. 57:114-123.
2. Balzi, E., W. Chen, S. Ulaszewski, E. Capieaux, and A. Goffeau. 1987. The multidrug resistance gene PDR1 from Saccharomyces cerevisiae. J. Biol. Chem. 262:16871-16879.
3. Black, S. M., and C. R. Wolf. 1991. The role of glutathione-dependent enzymes in drug resistance. Pharmacol. Ther. 51:139-154.
4. Buser, K., F. Joncourt, H. J. Altermatt, M. Bacchi, A. Oberli, and T. Cerny. 1997. Breast cancer: pretreatment drug resistance parameters (GSH-system, ATase, P-glycoprotein) in tumor tissue and their correlation with clinical and prognostic characteristics. Ann. Oncol. 8:335-341.
5. De Backer, M. D., T. Ilyina, X. J. Ma, S. Vandoninck, W. H. Luyten, and H. Vanden Bossche. 2001. Genomic profiling of the response of Candida albicans to itraconazole treatment using a DNA microarray. Antimicrob. Agents Chemother. 45:1660-1670.
6. Delaveau, T., A. Delahodde, E. Carvajal, J. Subik, and C. Jacq. 1994. PDR3, a new yeast regulatory gene, is homologous to PDR1 and controls the multidrug resistance phenomenon. Mol. Gen. Genet. 244:501-511.
7. DeRisi, J., B. van den Hazel, P. Marc, E. Balzi, P. Brown, C. Jacq, and A. Goffeau. 2000. Genome microarray analysis of transcriptional activation in multidrug resistance yeast mutants. FEBS Lett. 470:156-160.
8. Doroshow, J. H., S. Akman, F. F. Chu, and S. Esworthy. 1990. Role of the glutathione-glutathione peroxidase cycle in the cytotoxicity of the anticancer quinones. Pharmacol. Ther. 47:359-370.
9. Feigal, D. W., M. H. Katz, D. Greenspan, J. Westenhouse, W. Winkelstein, Jr., W. Lang, M. Samuel, M., S. P. Buchbinder, N. A. Hessol, and A. R. Lifson, et al. 1991. The prevalence of oral lesions in HIV-infected homosexual and bisexual men: three San Francisco epidemiological cohorts. AIDS 5:519-525.
10. Fernandez, F., J. S. Rush, D. A. Toke, G. S. Han, J. E. Quinn, G. M. Carman, J. Y. Choi, D. R. Voelker, M. Aebi, and C. J. Waechter. The CWH8 gene encodes a dolichyl pyrophosphate phosphatase with a luminally oriented active site in the endoplasmic reticulum of Saccharomyces cerevisiae. J. Biol. Chem. 276:41455-41464.
11. Franz, R., S. L. Kelly, D. C. Lamb, D. E. Kelly, M. Ruhnke, and J. Morschhäuser. 1998. Multiple molecular mechanisms contribute to a stepwise development of fluconazol resistance in clinical Candida albicans strains. Antimicrob. Agents Chemother. 42:3065-3072.
12. Franz, R., M. Ruhnke, and J. Morschhäuser. 1999. Molecular aspects of fluconazole resistance development in Candida albicans. Mycoses 42:453-458.
13. Gamonet, F., and G. J. Lauquin. 1998. The Saccharomyces cerevisiae LYS7 gene is involved in oxidative stress protection. Eur. J. Biochem. 251:716-723.
14. Garrad, R. C., and J. K. Bhattacharjee. 1992. Lysine biosynthesis in selected pathogenic fungi: characterization of lysine auxotrophs and the cloned LYS1 gene of Candida albicans. J. Bacteriol. 174:7379-7384.
15. Hallstrom, T. C., and W. S. Moye-Rowley. 2000. Multiple signals from dysfunctional mitochondria activate the pleiotropic drug resistance pathway in Saccharomyces cerevisiae. J. Biol. Chem. 275:37347-37356.
16. Kan, V. L., A. Geber, and J. E. Bennett. 1996. Enhanced oxidative killing of azole-resistant Candida glabrata strains with ERG11 deletion. Antimicrob. Agents Chemother. 40:1717-1719.
17. Kaur, R., and A. K. Bachhawat. 1999. The yeast multidrug resistance pump, Pdr5p, confers reduced drug resistance in erg mutants of Saccharomyces cerevisiae. Microbiology 145:809-818.
18. Klein, R. S., C. A. Harris, C. B. Small, B. Moll, M. Lesser, and G. H. Friedland. 1984. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N. Engl. J. Med. 311:354-358.
19. Klepser, M. E., D. Malone, R. E. Lewis, E. J. Ernst, and M. A. Pfaller. 2000. Evaluation of voriconazole pharmacodynamics using time-kill methodology. Antimicrob. Agents Chemother. 44:1917-1920.
20. Kuipers, M. E., H. G. de Vries, M. C. Eikelboom, D. K. Meijer, and P. J. Swart. 1999. Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates. Antimicrob. Agents Chemother. 43:2635-2641.
21. Kurita, O., and Y. Nishida. 1999. Involvement of mitochondrial aldehyde dehydrogenase ALD5 in maintenance of the mitochondrial electron transport chain in Saccharomyces cerevisiae. F. E. M. S. Microbiol. Lett. 181:281-287.
22. Lee, W. P., C. L. Lee, and H. C. Lin. 1996. Glutathione S-transferase and glutathione peroxidase are essential in the early stage of adriamycin resistance before P-glycoprotein overexpression in HOB1 lymphoma cells. Cancer Chemother. Pharmacol. 38:45-51.
23. Leidich, S. D., and P. Orlean. 1996. Gpil, a Saccharomyces cerevisiae protein that participates in the first step in glycosylphosphatidylinositol anchor synthesis. J. Biol. Chem. 271:27829-27837.
24. Lopez-Ribot, J. L., R. K. McAtee, L. N. Lee, W. R. Kirkpatrick, T. C. White, D. Sanglard, and T. F. Patterson. 1998. Distinct patterns of gene expression associated with development of fluconazole resistance in serial Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis. Antimicrob. Agents Chemother. 42:2932-2937.
25. Lyons, C. N., and T. C. White. 2000. Transcriptional analyses of antifungal drug resistance in Candida albicans. Antimicrob. Agents Chemother, 44; 2296-2303
26. Marr, K. A., T. C. White, J. A. van Burik, and R. A. Bowden. 1997. Development of fluconazole resistance in Candida albicans causing disseminated infection in a patient undergoing marrow transplantation. Clin. Infect. Dis. 25:908-910.
27. Micheli, M. M., J. Bille, C. Schueller, and D. Sanglard. 2002. A common drug-responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance. Mol. Microbiol. 43:1197-1214.
28. Minn, Y., E. Brummer, and D. A. Stevens. 1997. Effect of iron on fluconazole activity against Candida albicans in presence of human serum or monocyte-derived macrophages. Mycopathologia 138:29-35.
29. Nawrocki, A., S. J. Fey, A. Goffeau, P. Roepstorff, and P. M. Larsen. 2001. The effects of transcription regulating genes PDR1, pdr1-3, and PDR3 in pleiotropic drug resistance. Proteomics 1:1022-1032.
30. Perea, S., J. L. Lopez-Ribot, W. R. Kirkpatrick, R. K. McAtee, R. A. Santillan, M. Martinez, D. Calabrese, D. Sanglard, and T. F. Patterson. 2001. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 45:2676-2684.
31. Pfaller, M. A., J. Rhine-Chalberg, S. W. Redding, J. Smith, G. Farinacci, A. W. Fothergill, and M. G. Rinaldi. 1994. Variations in fiuconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. J. Clin. Microbiol. 32:59-64.
32. Redding, S., J. Smith, G. Farinacci, M. Rinaldi, A. Fothergill, J. Rhine-Chalberg, and M. Pfaller. 1994. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin. Infect. Dis. 18:240-242.
33. Richard, M., S. Ibata-Ombetta, F. Dromer, F. Bordon-Pallier, T. Jouault, and C. Gaillardin. 2002. Complete glycosylphosphatidylinositol anchors are required in Candida albicans for full morphogenesis, virulence and resistance to macrophages. Mol. Microbiol. 44:841-853.
34. Riggle, P. J., and C. A. Kumamoto. 2000. Role of a Candida albicans P1-type ATPase in resistance to copper and silver ion toxicity. J. Bacteriol. 182:4899-4905.
35. Sanglard, D., K. Kuchler, F. Ischer, J. L. Pagani, M. Monod, and J. Bille. 1995. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39:2378-2386.
36. Sanglard, D., F. Ischer, L. Koymans, and J. Bille. 1998. Amino acid substitutions in the cytochrome P-450 lanosterol 14α-demethylase (CYP51AI) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents. Antimicrob. Agents Chemother. 42:241-253.
37. Soustre, I., Y. Letourneux, and F. Karst. 1996. Characterization of the Saccharomyces cerevisiae RTA1 gene involved in 7-aminocholesterol resistance. Curr. Genet. 30:121-125.
38. Viarengo, A., B. Burlando, N. Ceratto, and I. Panfoli. 2000. Antioxidant role of metallothioneins: a comparative overview. Cell. Mol. Biol. 46:407-417.
39. Wakabayashi, H., T. Okutomi, S. Abe, H. Hayasawa, M. Tomita, and H. Yamaguchi. 1998. Enhanced anti-Candida activity of neutrophils and azole antifungal agents in the presence of lactoferrin-related compounds. Adv. Exp. Med. Biol. 443:229-237.
40. White, T. C. 1997. Increased mRNA levels of ERG16, CDR, and MDRI correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 41:1482-1487.
41. White, T. C. 1997. The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14α demethylase in Candida albicans. Antimicrob. Agents Chemother. 41:1488-1494.
42. White, T. C., K. A. Marr, and R. A. Bowden. 1998. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin. Microbiol. Rev. 11:382-402.
43. Wu, T., K. Wright, S. F. Hurst, and C. J. Morrison. 2000. Enhanced extracellular production of aspartyl proteinase, a virulence factor, by Candida albicans isolates following growth in subinhibitory concentrations of fluconazole. Antimicrob. Agents Chemother. 44:1200-1208.